Innovative Clinical Research Institute Will Become TOI Clinical Research The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the
Prostate cancer affects men second most commonly after skin cancer. Take 5 minutes to read about the prostate and some common myths about prostate cancer.
Value-based Oncology Leader Improving Access to Cutting-Edge Therapies CERRITOS, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) — The Oncology Institute, Inc. (NASDAQ: TOI), today announces the